Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Vir Biotechnology, Inc. (VIR) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$3.03M |
|
$-120.97M |
|
-- |
|
$3.03M |
|
$142.58M |
|
$-139.55M |
|
$18.60M |
|
$-120.95M |
|
$-120.95M |
|
$-120.97M |
|
$-120.97M |
|
$-120.97M |
|
$-120.97M |
|
$-139.55M |
|
$-132.59M |
|
137.47M |
|
137.47M |
|
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$932.21M |
|
$61.68M |
|
$375.52M |
|
$1.31B |
|
$137.29M |
|
-- |
|
$126.62M |
|
$263.91M |
|
$1.04B |
|
$1.02B |
|
$1.04B |
|
138.06M |
|
| Cash Flow Statement Financials | |
$-78.12M |
|
$126.82M |
|
$0.60M |
|
$318.69M |
|
$368.00M |
|
$49.30M |
|
$14.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.79 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-4602.47% |
|
-4602.47% |
|
-- |
|
-3989.08% |
|
-3989.61% |
|
$-79.46M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-11.59% |
|
-11.87% |
|
-9.25% |
|
-11.59% |
|
$7.56 |
|
$-0.58 |
|
$-0.57 |
|